WHO Guideline: Summary of recommendations on pharmaceutical pricing policies

How will the new WHO recommendations on pharmaceutical pricing policies affect your organization?

The WHO recently launched a series of recommendations on pharmaceutical pricing policies to help countries make medicines more affordable for the global population and lessen the burden on government budgets.

Alira Health’s Nerea Blanque-Catalina, VP, Market Access & Pricing, and Luis Culla, Associate Director, Global Market Access, dive into these new recommendations and provide advice on how companies can manage the impact of these new guidelines.

For more information and to connect with the team, contact Nerea at nerea.blanque@alirahealth.com or Luis at luis.culla@alirahealth.com.